Clinical Trial Update: Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating growth hormone, glutamine, and diet in short bowel syndrome was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Snippet

Sponsor: University of Nebraska | Conditions: Short Bowel Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2023-07-28